Phase 2 Study of BC-819 in Patients with Non-Muscle Invasive Bladder Cancer Whose Disease is Unresponsive to Bacillus Calmette-Guerin

Administered By

Contributors

Start/End

  • June 13, 2019 - June 30, 2023